RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.

doi:10.1016/j.neulet.2008.03.065

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.

Neuroscience letters - 23 May 2008

Huuhka Kaija, Kampman Olli, Anttila Sami, Huuhka Martti, Rontu Riikka, Mattila Kari M, Hurme Mikko, Lehtimäki Terho, Leinonen Esa

Abstract excerpt

We studied the association between RGS4 (rs951436) polymorphism and treatment response in electroconvulsive therapy (ECT) as well as risk of treatment-resistant depression. The study sample consisted of 119 patients with major depressive disorder (MDD) and 384 healthy control subjects. RGS4 polymorphism was not associated with treatment response in ECT or risk of MDD. According to the present data, the impact of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5' Untranslated Regions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Antidepressive Agents

Share to Depressive Disorder, Major

Share to Drug Resistance

Share to Psychiatric Status Rating Scales

Share to RGS Proteins

Share to Young Adult

Source

Open in PubMed

Identifiers

PMID: 18434012
DOI: 10.1016/j.neulet.2008.03.065

Genes

RGS4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.PMID 18434012Read ↗

Genetics of Response to ECT, TMS, Ketamine and Esketamine.Semantic proximity Read ↗

Influence of GRIK4 genetic variants on the electroconvulsive therapy response.Semantic proximity Read ↗

No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.Semantic proximity Read ↗

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.Semantic proximity Read ↗

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.Semantic proximity Read ↗

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)Semantic proximity Read ↗

Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.Semantic proximity Read ↗

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.Semantic proximity Read ↗

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.Semantic proximity Read ↗

The role of GRIK4 gene in treatment-resistant depression.Semantic proximity Read ↗

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.Semantic proximity Read ↗

Apolipoprotein E polymorphism and response to electroconvulsive therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.